Authorized purpose: Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.
Keep in mind: Adult cardiac acquisition assistance with compatible ultrasound systems and trained medical users; acquired views are assessed by qualified professionals. Version 1.3.0 adds an iPhone portrait interface while retaining the clinical acquisition functions.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Heart/Cardiovascular Input: Live ultrasound images for PLAX, PSAX-AV, PSAX-MV, PSAX-PM, A4C, A5C, A2C, A3C, SC-4C and SC-IVC views; the submission describes Butterfly iQ+ and iQ3 compatibility under the predicate PCCP.
Who uses it?Intended users: Medical professionals trained in ultrasound basics and HeartFocus using DESKi training or approved materials delivered by a trained medical professional.
What does the software produce?Output: Probe-position guidance, image-quality feedback and recorded echocardiographic clips that the user can review and save.
What is its most important limitation?Key limitation: Adult cardiac acquisition assistance with compatible ultrasound systems and trained medical users; acquired views are assessed by qualified professionals. Version 1.3.0 adds an iPhone portrait interface while retaining the clinical acquisition functions.
Clinical takeaway. Clinical role: Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.
Evidence takeaway. Evidence from the reviewed source record: The exact submission evaluates a mobile-platform modification and probe compatibility; historical family clinical evidence must be linked separately before applying it to v1.3.0.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Guides medical professionals acquiring ten standard 2D transthoracic echocardiographic views in adults requiring a cardiac ultrasound examination; acquired images require qualified clinical interpretation.
Live ultrasound images for PLAX, PSAX-AV, PSAX-MV, PSAX-PM, A4C, A5C, A2C, A3C, SC-4C and SC-IVC views; the submission describes Butterfly iQ+ and iQ3 compatibility under the predicate PCCP.
Medical professionals trained in ultrasound basics and HeartFocus using DESKi training or approved materials delivered by a trained medical professional.
Adult cardiac acquisition assistance with compatible ultrasound systems and trained medical users; acquired views are assessed by qualified professionals. Version 1.3.0 adds an iPhone portrait interface while retaining the clinical acquisition functions.
The exact submission evaluates a mobile-platform modification and probe compatibility; historical family clinical evidence must be linked separately before applying it to v1.3.0.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The exact submission evaluates a mobile-platform modification and probe compatibility; historical family clinical evidence must be linked separately before applying it to v1.3.0.
The reviewed exact-release summary reports acquisition and quality metrics, not a disease-detection sensitivity with an applicable clinical endpoint.
Reported specificity
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-05
A disease-detection specificity for HeartFocus v1.3.0 was not established by the reviewed summary.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
HeartFocus v1.3.0 Special 510(k) verification and validation
DesignSimulated-use usability evaluation and historical-image AI validation, with software and cybersecurity verification.
PopulationEight representative novice medical professionals with basic ultrasound training in a simulated iPhone/iQ3 workflow; separate historical validation used 40 US and 40 non-US patients.
Scopeexact submission
Tested versionHeartFocus v1.3.0
IndependenceIndependence not established
K260780
No new clinical investigation for K260780. The historical-image cohort is distinct from the eight-participant usability evaluation; no diagnostic-outcome metric is inferred.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Pricing & contractsPublic price, contract terms, and reimbursement
Pricing is recorded, but no exact-product procurement price with a stated offer scope is published in the reviewed sources.
Public pricing
The current HeartFocus pricing page lists $695 per license/year/probe or $1,800 per license/three years/probe for up to five licenses, with unlimited users. Enterprise plans for six or more licenses require a custom quote.
Product family
Checked 2026-09-06
The page uses a dollar symbol without an ISO currency designation and does not identify v1.3.0. This is a current family offer, not an exact-version quote; structured prices remain empty pending currency and contract confirmation.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Live ultrasound images for PLAX, PSAX-AV, PSAX-MV, PSAX-PM, A4C, A5C, A2C, A3C, SC-4C and SC-IVC views; the submission describes Butterfly iQ+ and iQ3 compatibility under the predicate PCCP.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The application performs its acquisition functions offline and stores medical data locally on the mobile device; the summary states that these data are not sent to a DESKi-controlled server. The change supports iPhone with iOS 17 or later, an A12 Bionic CPU and a minimum 4.7-inch display.
Scope: Exact FDA submission. This describes the cleared application boundary, not every connected PACS or enterprise export configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Probe-position guidance, image-quality feedback and recorded echocardiographic clips that the user can review and save.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Probe-position guidance, image-quality feedback and recorded echocardiographic clips that the user can review and save.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The application performs its acquisition functions offline and stores medical data locally on the mobile device; the summary states that these data are not sent to a DESKi-controlled server. The change supports iPhone with iOS 17 or later, an A12 Bionic CPU and a minimum 4.7-inch display.
Exact FDA submission
Checked 2026-09-05
This describes the cleared application boundary, not every connected PACS or enterprise export configuration.
DESKi's coordinated vulnerability disclosure policy, scoped to DESKi products and services, provides security researcher prerequisites (no patient-safety risk, written permission before testing, coordinated public disclosure timing), an encrypted reporting channel (security@deski.ai with a public PGP key), and handling expectations for vulnerability reports.
Vendor-wide
Checked 2026-10-27
Vendor CVD policy naming DESKi on the HeartFocus product site (heartfocus.ai), which uses the deski.ai contact domain. Exact-release scope is not established.
DESKi's coordinated vulnerability disclosure policy, scoped to DESKi products and services, states acknowledgement of receipt within two business days, investigation and risk analysis of reported vulnerabilities, and a summary of findings provided to the submitter.
Vendor-wide
Checked 2026-10-27
Vendor statement, not an attestation. The policy names DESKi products and services generally and does not scope these commitments to any specific product release; exact-release scope is not established. This is an intake and response-handling commitment; it states no uptime, drift or continuous-monitoring claims.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-06Last searched
18Fields reviewed
9Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads
Stored title PROSPECTIVE EVALUATION OF HEARTFOCUS and DESKi sponsor support a product-family lead. Exact tested version and registry results require full-record review; no trial performance promoted. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, vendor product page, vendor pricing observation, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded web search on 2026-10-26 (query: "Deski HeartFocus reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.
Ligence Heart is a fully automated software platform that processes, analyses and makes measurements on acquired transthoracic cardiac ultrasound images, automatically producing a full report with measurements of several key cardiac structural and functional parameters. The data produced by this software is intended to be used to support qualified cardiologists or sonographers for clinical decision making. Ligence Heart is indicated for use in adult patients. Ligence Heart has not been validated for the assessment of congenital heart disease, valve disease, pericardial disease, and/or intra-cardiac lesions (e.g., tumors, thrombi). Limitations: Poor image capture will lead to poor annotations and subsequent measurements. Multiple image quality algorithms are used to filter out images of poor quality. Our software complements good patient care and does not exempt the user from the responsibility to provide supervision, clinically review the patient, and make appropriate clinical decisions. If no gender is present, female referenced guideline values will be used for conclusions. If Body Surface Area (BSA) is not present, indexed values cannot be provided. During image acquisition, inappropriate use of the echo machine, use of non-cardiac ultrasound probes, or use of suboptimal settings (e.g., gain, contrast, depth) may lead to lower accuracy of the software. Ligence Heart has not been validated in patients with prosthetic or surgically altered cardiac valves, implantable intracardiac devices, or irregular (non-sinus) rhythm; these conditions may affect automated measurement accuracy.
Authorized purpose: PVAD IQ supports qualified-physician clinical decision support by identifying the aortic annulus and PVAD inlet, calculating their mean distance, and identifying clips acceptable for this measurement.
Authorized purpose: HeartFocus v1.1.1 guides trained medical professionals in acquiring ten standard adult 2D transthoracic echocardiographic views using compatible ultrasound systems, with live probe guidance, image-quality feedback and recording assistance for subsequent clinical interpretation.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.